Skip to main content
PMC home page
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 1999 Aug;33(4):231–238. doi: 10.1136/bjsm.33.4.231

The oral contraceptive pill: a revolution for sportswomen?

K Bennell, S White, K Crossley
PMCID: PMC1756183  PMID: 10450476

Abstract

OBJECTIVES: To determine the effects of the oral contraceptive pill (OCP) on skeletal health, soft tissue injury, and performance in female athletes. METHODS: A literature review was performed using literature retrieval methods to locate relevant studies. RESULTS: Most female athletes primarily choose to use the OCP for contraceptive purposes, but cycle manipulation and control of premenstrual symptoms are secondary advantages of its use. The effect of the OCP on bone density in normally menstruating women is unclear, with some studies reporting no effect, others a positive effect, and some even a negative effect. The OCP is often prescribed for the treatment of menstrual disturbances in female athletes, and improvements in bone density may result. Whether the OCP influences the risk of stress fracture and soft tissue injuries is not clear from research to date. Effects of the OCP on performance are particularly relevant for elite sportswomen. Although a reduction in Vo2MAX has been reported in some studies, this may not necessarily translate to impaired performance in the field. Moreover, some studies claim that the OCP may well enhance performance by reducing premenstrual symptoms and menstrual blood loss. A fear of weight gain with the use of the OCP is not well founded, as population studies report no effect on weight, particularly with the lower dose pills currently available. CONCLUSIONS: Overall, the advantages of the pill for sportswomen would appear to outweigh any potential disadvantages. Nevertheless, there is individual variation in response to the OCP and these should be taken into account and monitored in the clinical situation. Women should be counselled as to the range of potential benefits and disadvantages in order to make an informed decision based on individual circumstances. 




Full Text

The Full Text of this article is available as a PDF (101.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrow G. W., Saha S. Menstrual irregularity and stress fractures in collegiate female distance runners. Am J Sports Med. 1988 May-Jun;16(3):209–216. doi: 10.1177/036354658801600302. [DOI] [PubMed] [Google Scholar]
  2. Bemben D. A., Boileau R. A., Bahr J. M., Nelson R. A., Misner J. E. Effects of oral contraceptives on hormonal and metabolic responses during exercise. Med Sci Sports Exerc. 1992 Apr;24(4):434–441. [PubMed] [Google Scholar]
  3. Bennell K. L., Crossley K. Musculoskeletal injuries in track and field: incidence, distribution and risk factors. Aust J Sci Med Sport. 1996 Sep;28(3):69–75. [PubMed] [Google Scholar]
  4. Bennell K. L., Malcolm S. A., Thomas S. A., Ebeling P. R., McCrory P. R., Wark J. D., Brukner P. D. Risk factors for stress fractures in female track-and-field athletes: a retrospective analysis. Clin J Sport Med. 1995 Oct;5(4):229–235. doi: 10.1097/00042752-199510000-00004. [DOI] [PubMed] [Google Scholar]
  5. Bennell K. L., Malcolm S. A., Thomas S. A., Reid S. J., Brukner P. D., Ebeling P. R., Wark J. D. Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am J Sports Med. 1996 Nov-Dec;24(6):810–818. doi: 10.1177/036354659602400617. [DOI] [PubMed] [Google Scholar]
  6. Brady W. A., Kritz-Silverstein D., Barrett-Connor E., Morales A. J. Prior oral contraceptive use is associated with higher blood pressure in older women. J Womens Health. 1998 Mar;7(2):221–228. doi: 10.1089/jwh.1998.7.221. [DOI] [PubMed] [Google Scholar]
  7. Bryner R. W., Toffle R. C., Ullrich I. H., Yeater R. A. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med. 1996 Mar;30(1):36–40. doi: 10.1136/bjsm.30.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brynhildsen J. O., Hammar J., Hammar M. L. Does the menstrual cycle and use of oral contraceptives influence the risk of low back pain? A prospective study among female soccer players. Scand J Med Sci Sports. 1997 Dec;7(6):348–353. doi: 10.1111/j.1600-0838.1997.tb00165.x. [DOI] [PubMed] [Google Scholar]
  9. Carbon R., Sambrook P. N., Deakin V., Fricker P., Eisman J. A., Kelly P., Maguire K., Yeates M. G. Bone density of élite female athletes with stress fractures. Med J Aust. 1990 Oct 1;153(7):373–376. doi: 10.5694/j.1326-5377.1990.tb125491.x. [DOI] [PubMed] [Google Scholar]
  10. Carter D. R., Hayes W. C., Schurman D. J. Fatigue life of compact bone--II. Effects of microstructure and density. J Biomech. 1976;9(4):211–218. doi: 10.1016/0021-9290(76)90006-3. [DOI] [PubMed] [Google Scholar]
  11. Cooper C., Hannaford P., Croft P., Kay C. R. Oral contraceptive pill use and fractures in women: a prospective study. Bone. 1993;14(1):41–45. doi: 10.1016/8756-3282(93)90254-8. [DOI] [PubMed] [Google Scholar]
  12. Cumming D. C. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med. 1996 Oct 28;156(19):2193–2195. [PubMed] [Google Scholar]
  13. Daugherty J. E. Treatment strategies for premenstrual syndrome. Am Fam Physician. 1998 Jul;58(1):183-92, 197-8. [PubMed] [Google Scholar]
  14. Davee A. M., Rosen C. J., Adler R. A. Exercise patterns and trabecular bone density in college women. J Bone Miner Res. 1990 Mar;5(3):245–250. doi: 10.1002/jbmr.5650050307. [DOI] [PubMed] [Google Scholar]
  15. De Bruyn-Prevost P., Masset C., Sturbois X. Physiological response from 18-25 years women to aerobic and anaerobic physical fitness tests at different periods during the menstrual cycle. J Sports Med Phys Fitness. 1984 Jun;24(2):144–148. [PubMed] [Google Scholar]
  16. De Crée C., Lewin R., Ostyn M. Suitability of cyproterone acetate in the treatment of osteoporosis associated with athletic amenorrhea. Int J Sports Med. 1988 Jun;9(3):187–192. doi: 10.1055/s-2007-1025002. [DOI] [PubMed] [Google Scholar]
  17. Drinkwater B. L., Nilson K., Chesnut C. H., 3rd, Bremner W. J., Shainholtz S., Southworth M. B. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 1984 Aug 2;311(5):277–281. doi: 10.1056/NEJM198408023110501. [DOI] [PubMed] [Google Scholar]
  18. Düsterberg B., Ellman H., Müller U., Rowe E., Mühe B. A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene. Gynecol Endocrinol. 1996 Feb;10(1):33–39. doi: 10.3109/09513599609041268. [DOI] [PubMed] [Google Scholar]
  19. Fogelholm M. Indicators of vitamin and mineral status in athletes' blood: a review. Int J Sport Nutr. 1995 Dec;5(4):267–284. doi: 10.1123/ijsn.5.4.267. [DOI] [PubMed] [Google Scholar]
  20. Frusztajer N. T., Dhuper S., Warren M. P., Brooks-Gunn J., Fox R. P. Nutrition and the incidence of stress fractures in ballet dancers. Am J Clin Nutr. 1990 May;51(5):779–783. doi: 10.1093/ajcn/51.5.779. [DOI] [PubMed] [Google Scholar]
  21. Garnero P., Sornay-Rendu E., Delmas P. D. Decreased bone turnover in oral contraceptive users. Bone. 1995 May;16(5):499–503. doi: 10.1016/8756-3282(95)00075-o. [DOI] [PubMed] [Google Scholar]
  22. Gossain V. V., Sherma N. K., Michelakis A. M., Rovner D. R. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. Am J Obstet Gynecol. 1983 Nov 15;147(6):618–623. doi: 10.1016/0002-9378(83)90437-4. [DOI] [PubMed] [Google Scholar]
  23. Gray D. P., Harding E., Dale E. Effects of oral contraceptives on serum lipid profiles of women runners. Fertil Steril. 1983 Apr;39(4):510–514. doi: 10.1016/s0015-0282(16)46942-6. [DOI] [PubMed] [Google Scholar]
  24. Hama H., Yamamuro T., Takeda T. Experimental studies on connective tissue of the capsular ligament. Influences of aging and sex hormones. Acta Orthop Scand. 1976 Oct;47(5):473–479. doi: 10.3109/17453677608988723. [DOI] [PubMed] [Google Scholar]
  25. Hansen M. A. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. Osteoporos Int. 1994 May;4(3):123–128. doi: 10.1007/BF01623056. [DOI] [PubMed] [Google Scholar]
  26. Hansen M. A., Overgaard K., Christiansen C. Spontaneous postmenopausal bone loss in different skeletal areas--followed up for 15 years. J Bone Miner Res. 1995 Feb;10(2):205–210. doi: 10.1002/jbmr.5650100206. [DOI] [PubMed] [Google Scholar]
  27. Harlow S. D., Linet M. S. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol. 1989 Feb;129(2):233–248. doi: 10.1093/oxfordjournals.aje.a115129. [DOI] [PubMed] [Google Scholar]
  28. Hartard M., Bottermann P., Bartenstein P., Jeschke D., Schwaiger M. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity. Contraception. 1997 Feb;55(2):87–90. doi: 10.1016/s0010-7824(96)00277-6. [DOI] [PubMed] [Google Scholar]
  29. Heaney R. P., Recker R. R., Saville P. D. Menopausal changes in calcium balance performance. J Lab Clin Med. 1978 Dec;92(6):953–963. [PubMed] [Google Scholar]
  30. Hergenroeder A. C., Smith E. O., Shypailo R., Jones L. A., Klish W. J., Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997 May;176(5):1017–1025. doi: 10.1016/s0002-9378(97)70396-x. [DOI] [PubMed] [Google Scholar]
  31. Hreshchyshyn M. M., Hopkins A., Zylstra S., Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol. 1988 Aug;159(2):318–322. doi: 10.1016/s0002-9378(88)80075-9. [DOI] [PubMed] [Google Scholar]
  32. Jarrett J. C., 2nd, Spellacy W. N. Contraceptive practices of female runners. Fertil Steril. 1983 Mar;39(3):374–375. doi: 10.1016/s0015-0282(16)46887-1. [DOI] [PubMed] [Google Scholar]
  33. Johnston S. C., Colford J. M., Jr, Gress D. R. Oral contraceptives and the risk of subarachnoid hemorrhage: a meta-analysis. Neurology. 1998 Aug;51(2):411–418. doi: 10.1212/wnl.51.2.411. [DOI] [PubMed] [Google Scholar]
  34. Kadel N. J., Teitz C. C., Kronmal R. A. Stress fractures in ballet dancers. Am J Sports Med. 1992 Jul-Aug;20(4):445–449. doi: 10.1177/036354659202000414. [DOI] [PubMed] [Google Scholar]
  35. Keay N., Fogelman I., Blake G. Bone mineral density in professional female dancers. Br J Sports Med. 1997 Jun;31(2):143–147. doi: 10.1136/bjsm.31.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lebrun C. M. Effect of the different phases of the menstrual cycle and oral contraceptives on athletic performance. Sports Med. 1993 Dec;16(6):400–430. doi: 10.2165/00007256-199316060-00005. [DOI] [PubMed] [Google Scholar]
  37. Lehtovirta P., Kuikka J., Pyörälä T. Hemodynamic effects of oral contraceptives during exercise. Int J Gynaecol Obstet. 1977;15(1):35–37. doi: 10.1002/j.1879-3479.1977.tb00639.x. [DOI] [PubMed] [Google Scholar]
  38. Lindsay R., Tohme J., Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception. 1986 Oct;34(4):333–340. doi: 10.1016/0010-7824(86)90086-7. [DOI] [PubMed] [Google Scholar]
  39. Littler W. A., Bojorges-Bueno R., Banks J. Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy. Thorax. 1974 Sep;29(5):567–570. doi: 10.1136/thx.29.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Liu S. H., Al-Shaikh R. A., Panossian V., Finerman G. A., Lane J. M. Estrogen affects the cellular metabolism of the anterior cruciate ligament. A potential explanation for female athletic injury. Am J Sports Med. 1997 Sep-Oct;25(5):704–709. doi: 10.1177/036354659702500521. [DOI] [PubMed] [Google Scholar]
  41. Lloyd T., Triantafyllou S. J., Baker E. R., Houts P. S., Whiteside J. A., Kalenak A., Stumpf P. G. Women athletes with menstrual irregularity have increased musculoskeletal injuries. Med Sci Sports Exerc. 1986 Aug;18(4):374–379. [PubMed] [Google Scholar]
  42. Lynch N. J., Nimmo M. A. Effects of menstrual cycle phase and oral contraceptive use on intermittent exercise. Eur J Appl Physiol Occup Physiol. 1998 Nov;78(6):565–572. doi: 10.1007/s004210050462. [DOI] [PubMed] [Google Scholar]
  43. Micklesfield L. K., Lambert E. V., Fataar A. B., Noakes T. D., Myburgh K. H. Bone mineral density in mature, premenopausal ultramarathon runners. Med Sci Sports Exerc. 1995 May;27(5):688–696. [PubMed] [Google Scholar]
  44. Mishell D. R., Jr Noncontraceptive benefits of oral contraceptives. J Reprod Med. 1993 Dec;38(12 Suppl):1021–1029. [PubMed] [Google Scholar]
  45. Myburgh K. H., Hutchins J., Fataar A. B., Hough S. F., Noakes T. D. Low bone density is an etiologic factor for stress fractures in athletes. Ann Intern Med. 1990 Nov 15;113(10):754–759. doi: 10.7326/0003-4819-113-10-754. [DOI] [PubMed] [Google Scholar]
  46. Möller-Nielsen J., Hammar M. Women's soccer injuries in relation to the menstrual cycle and oral contraceptive use. Med Sci Sports Exerc. 1989 Apr;21(2):126–129. [PubMed] [Google Scholar]
  47. Notelovitz M., Zauner C., McKenzie L., Suggs Y., Fields C., Kitchens C. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol. 1987 Mar;156(3):591–598. doi: 10.1016/0002-9378(87)90059-7. [DOI] [PubMed] [Google Scholar]
  48. Petrofsky J. S., LeDonne D. M., Rinehart J. S., Lind A. R. Isometric strength and endurance during the menstrual cycle. Eur J Appl Physiol Occup Physiol. 1976 Mar 9;35(1):1–10. doi: 10.1007/BF00444652. [DOI] [PubMed] [Google Scholar]
  49. Pettersson U., Stålnacke B., Ahlénius G., Henriksson-Larsén K., Lorentzon R. Low bone mass density at multiple skeletal sites, including the appendicular skeleton in amenorrheic runners. Calcif Tissue Int. 1999 Feb;64(2):117–125. doi: 10.1007/s002239900589. [DOI] [PubMed] [Google Scholar]
  50. Phillips S. K., Rook K. M., Siddle N. C., Bruce S. A., Woledge R. C. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 1993 Jan;84(1):95–98. doi: 10.1042/cs0840095. [DOI] [PubMed] [Google Scholar]
  51. Phillips S. K., Sanderson A. G., Birch K., Bruce S. A., Woledge R. C. Changes in maximal voluntary force of human adductor pollicis muscle during the menstrual cycle. J Physiol. 1996 Oct 15;496(Pt 2):551–557. doi: 10.1113/jphysiol.1996.sp021706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Polatti F., Perotti F., Filippa N., Gallina D., Nappi R. E. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995 Apr;51(4):221–224. doi: 10.1016/0010-7824(95)00036-a. [DOI] [PubMed] [Google Scholar]
  53. Posthuma B. W., Bass M. J., Bull S. B., Nisker J. A. Detecting changes in functional ability in women with premenstrual syndrome. Am J Obstet Gynecol. 1987 Feb;156(2):275–278. doi: 10.1016/0002-9378(87)90267-5. [DOI] [PubMed] [Google Scholar]
  54. Prior J. C., Vigna Y. M., Barr S. I., Kennedy S., Schulzer M., Li D. K. Ovulatory premenopausal women lose cancellous spinal bone: a five year prospective study. Bone. 1996 Mar;18(3):261–267. doi: 10.1016/8756-3282(95)00487-4. [DOI] [PubMed] [Google Scholar]
  55. Prior J. C., Vigna Y. M., Barr S. I., Rexworthy C., Lentle B. C. Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med. 1994 Jun;96(6):521–530. doi: 10.1016/0002-9343(94)90092-2. [DOI] [PubMed] [Google Scholar]
  56. Prior J. C., Vigna Y. M., Schechter M. T., Burgess A. E. Spinal bone loss and ovulatory disturbances. N Engl J Med. 1990 Nov 1;323(18):1221–1227. doi: 10.1056/NEJM199011013231801. [DOI] [PubMed] [Google Scholar]
  57. ROUGIER G., LINQUETTE Y. [Menstruation and physical exercise]. Presse Med. 1962 Oct 6;70:1921–1923. [PubMed] [Google Scholar]
  58. Recker R. R., Davies K. M., Hinders S. M., Heaney R. P., Stegman M. R., Kimmel D. B. Bone gain in young adult women. JAMA. 1992 Nov 4;268(17):2403–2408. [PubMed] [Google Scholar]
  59. Register T. C., Jayo M. J., Jerome C. P. Oral contraceptive treatment inhibits the normal acquisition of bone mineral in skeletally immature young adult female monkeys. Osteoporos Int. 1997;7(4):348–353. doi: 10.1007/BF01623776. [DOI] [PubMed] [Google Scholar]
  60. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Results of daily measurements. Contraception. 1998 Dec;58(6):345–349. doi: 10.1016/s0010-7824(98)00127-9. [DOI] [PubMed] [Google Scholar]
  61. Sarwar R., Niclos B. B., Rutherford O. M. Changes in muscle strength, relaxation rate and fatiguability during the human menstrual cycle. J Physiol. 1996 May 15;493(Pt 1):267–272. doi: 10.1113/jphysiol.1996.sp021381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Schwingl P. J., Ory H. W., Visness C. M. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):241–249. doi: 10.1016/s0002-9378(99)70182-1. [DOI] [PubMed] [Google Scholar]
  63. Sciore P., Frank C. B., Hart D. A. Identification of sex hormone receptors in human and rabbit ligaments of the knee by reverse transcription-polymerase chain reaction: evidence that receptors are present in tissue from both male and female subjects. J Orthop Res. 1998 Sep;16(5):604–610. doi: 10.1002/jor.1100160513. [DOI] [PubMed] [Google Scholar]
  64. Skouby S. O., Andersen O., Petersen K. R., Mølsted-Pedersen L., Kühl C. Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):343–348. doi: 10.1016/0002-9378(90)90579-v. [DOI] [PubMed] [Google Scholar]
  65. Slemenda C., Hui S. L., Longcope C., Johnston C. C. Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest. 1987 Nov;80(5):1261–1269. doi: 10.1172/JCI113201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Smith B. A., Livesay G. A., Woo S. L. Biology and biomechanics of the anterior cruciate ligament. Clin Sports Med. 1993 Oct;12(4):637–670. [PubMed] [Google Scholar]
  67. Sowers M., Wallace R. B., Lemke J. H. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med. 1985 Sep;14(5):585–596. doi: 10.1016/0091-7435(85)90079-9. [DOI] [PubMed] [Google Scholar]
  68. Stacey E., Korkia P., Hukkanen M. V., Polak J. M., Rutherford O. M. Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J Clin Endocrinol Metab. 1998 Sep;83(9):3056–3061. doi: 10.1210/jcem.83.9.5106. [DOI] [PubMed] [Google Scholar]
  69. Taaffe D. R., Snow-Harter C., Connolly D. A., Robinson T. L., Brown M. D., Marcus R. Differential effects of swimming versus weight-bearing activity on bone mineral status of eumenorrheic athletes. J Bone Miner Res. 1995 Apr;10(4):586–593. doi: 10.1002/jbmr.5650100411. [DOI] [PubMed] [Google Scholar]
  70. Thompson H. S., Hyatt J. P., De Souza M. J., Clarkson P. M. The effects of oral contraceptives on delayed onset muscle soreness following exercise. Contraception. 1997 Aug;56(2):59–65. doi: 10.1016/s0010-7824(97)00093-0. [DOI] [PubMed] [Google Scholar]
  71. Tomten S. E., Falch J. A., Birkeland K. I., Hemmersbach P., Høstmark A. T. Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior. Int J Sports Med. 1998 Feb;19(2):92–97. doi: 10.1055/s-2007-971888. [DOI] [PubMed] [Google Scholar]
  72. Tzingounis V., Cardamakis E., Ginopoulos P., Argiropoulos G. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy). Anticancer Res. 1996 Nov-Dec;16(6C):3997–4000. [PubMed] [Google Scholar]
  73. Ursin G., Ross R. K., Sullivan-Halley J., Hanisch R., Henderson B., Bernstein L. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat. 1998 Jul;50(2):175–184. doi: 10.1023/a:1006037823178. [DOI] [PubMed] [Google Scholar]
  74. Warren M. P., Brooks-Gunn J., Hamilton L. H., Warren L. F., Hamilton W. G. Scoliosis and fractures in young ballet dancers. Relation to delayed menarche and secondary amenorrhea. N Engl J Med. 1986 May 22;314(21):1348–1353. doi: 10.1056/NEJM198605223142104. [DOI] [PubMed] [Google Scholar]
  75. Winfield A. C., Moore J., Bracker M., Johnson C. W. Risk factors associated with stress reactions in female Marines. Mil Med. 1997 Oct;162(10):698–702. [PubMed] [Google Scholar]
  76. Wirth J. C., Lohman T. G. The relationship of static muscle function to use of oral contraceptives. Med Sci Sports Exerc. 1982;14(1):16–20. doi: 10.1249/00005768-198201000-00003. [DOI] [PubMed] [Google Scholar]
  77. Wojtys E. M., Huston L. J., Lindenfeld T. N., Hewett T. E., Greenfield M. L. Association between the menstrual cycle and anterior cruciate ligament injuries in female athletes. Am J Sports Med. 1998 Sep-Oct;26(5):614–619. doi: 10.1177/03635465980260050301. [DOI] [PubMed] [Google Scholar]
  78. Wolman R. L., Clark P., McNally E., Harries M. G., Reeve J. Dietary calcium as a statistical determinant of spinal trabecular bone density in amenorrhoeic and oestrogen-replete athletes. Bone Miner. 1992 Jun;17(3):415–423. doi: 10.1016/0169-6009(92)90790-k. [DOI] [PubMed] [Google Scholar]
  79. Zanker C. L., Swaine I. L. Bone turnover in amenorrhoeic and eumenorrhoeic women distance runners. Scand J Med Sci Sports. 1998 Feb;8(1):20–26. doi: 10.1111/j.1600-0838.1998.tb00224.x. [DOI] [PubMed] [Google Scholar]
  80. Zanker C. L., Swaine I. L. Relation between bone turnover, oestradiol, and energy balance in women distance runners. Br J Sports Med. 1998 Jun;32(2):167–171. doi: 10.1136/bjsm.32.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES